Schein (Henry) Inc. (HSIC)

HEALTH CARE: HEALTH CARE SERVICES
SIC: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES

135 DURYEA RD MELVILLE, NY 11747

Schein (Henry) Inc. distributes healthcare products and services to office-based healthcare practitioners in the North American and European markets. Serves more than 500,000 customers worldwide, including dental practices and laboratories, physician practices, veterinary clinics, and government.

Data as of 2020-06-06
Market Cap9.398 Billion Shares Outstanding142.756 Million Avg 30-day Volume1.758 Million
P/E Ratio13.0 Dividend Yield EPS4.85
Price/Sales0.935 Price cash flow ratio12.0 Price free cash flow ratio10.0
Book Value20.84 Price to Tangible Book-177.92 Alpha-0.01
Short Interest Ratio % Short Interest to Float R-squared0.296422
BETA0.956959 52-week High/Low73.99 / 41.85 Stddev0.075453
View SEC Filings from HSIC instead.

View recent insider trading info

Funds Holding HSIC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HSIC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LASKAWY PHILIP A

  • Director
0 2020-06-01 2

SULLIVAN LOUIS W

  • Director
63,287 2020-05-21 0

PRANGE KAREN

  • Director
8,354 2020-05-20 0

GOODMAN SHIRA

  • Director
9,617 2020-05-14 1

MATTHEWS NORMAN S

  • Director
106,925 2020-05-13 0

PALADINO STEVEN

  • Director
0 2020-05-13 5

ROSS BRIDGET A

  • Director
0 2020-04-28 0

ALPERIN BARRY J

34,483 2020-04-17 2

MARGULIES ANNE H.

  • Director
11,107 2020-03-27 5

MLOTEK MARK E EVP, CHIEF STRATEGIC OFFICER

  • Officer
  • Director
123,864 2020-03-06 5

BERGMAN STANLEY M CHAIRMAN, CEO

  • Officer
  • Director
1,112,437 2020-03-06 6

BRESLAWSKI JAMES P VICE CHAIRMAN, PRESIDENT

  • Officer
  • Director
246,062 2020-03-06 5

BENJAMIN GERALD A EVP, CHIEF ADMIN. OFFICER

  • Officer
  • Director
134,304 2020-03-06 4

ETTINGER MICHAEL S SVP CORP/LEGAL CH OF STAFF SEC

  • Officer
95,693 2020-03-06 4

SIEGEL WALTER SENIOR VP & GENERAL COUNSEL

  • Officer
52,769 2020-03-06 4

BRONS PAUL

  • Director
17,536 2020-03-05 4

SHEARES BRADLEY T

  • Director
46,534 2020-03-05 2

RAPHAEL CAROL

  • Director
23,913 2020-03-05 2

KUEHN KURT P

  • Director
16,162 2020-03-05 2

REKOW E DIANNE

  • Director
15,558 2020-03-04 3

HERRING JOSEPH L

  • Director
15,232 2020-03-03 1

HAMBURG MARGARET A

  • Director
0 2019-07-01 0

MCKINLEY DAVID CCO&PRES. CORP. COM. DEV. GRP.

  • Officer
68,222 2018-11-30 0

BACOW LAWRENCE S

  • Director
0 2018-03-13 0

KABAT DONALD J

  • Director
29,286 2018-03-06 0

ROSE PAUL SVP, GLOBAL SUPPLY CHAIN

  • Officer
18,646 2017-09-06 0

MINOWITZ ROBERT PRES., INT'L DENTAL GROUP EMEA

  • Officer
26,182 2017-05-12 0

MCGLYNN LORELEI SVP, GLOBAL HR & FIN. OPER.

  • Officer
33,296 2017-03-23 0

RACIOPPI MICHAEL SVP CHIEF MERCHANDISING OFFIC.

  • Officer
23,385 2017-03-20 0

MCCARTHY PETER M. PRES., GLOBAL ANIMAL HEALTH

  • Officer
14,277 2017-03-13 0

HARDING JAMES A. SVP, CHIEF TECHNOLOGY OFFICER

  • Officer
39,355 2017-03-08 0

SHOFF LONNIE CEO, GLOBAL STRAT PORT GRP

  • Officer
31,000 2016-03-15 0

KOMAROFF STANLEY SENIOR ADVISOR

  • Officer
25,533 2016-03-01 0

DAVID LEONARD A SVP, CHIEF COMPLIANCE OFFICER

  • Officer
16,366 2015-03-17 0

MASHIMA KARYN

  • Director
19,269 2014-03-10 0

ZACK MICHAEL PRESIDENT OF INT'L GROUP

  • Officer
52,663 2013-03-07 0

SCHEIN MARVIN

  • FORMER DIRECTOR
No longer subject to file 2008-05-14 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments